Secondary Logo

Journal Logo

September-October 2005 - Volume 28 - Issue 5
pp: 427-516



Immune and Clinical Outcomes in Patients with Stage IV Melanoma Vaccinated with Peptide-Pulsed Dendritic Cells Derived From CD34+ Progenitors and Activated with Type I Interferon

Banchereau, Jacques; Ueno, Hideki; Dhodapkar, Madhav; More

Journal of Immunotherapy. 28(5):505-516, September-October 2005.